A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy

Cancer Chemotherapy and Pharmacology
A N VisG H J Mickisch

Abstract

Renal cell carcinoma (RCC) has a poor prognosis when metastasized to distant sites, although immunotherapy may offer a prolongation of survival in selected patient groups. Unfortunately, no treatment options remain when immunotherapy fails. In this phase IIa trial the tolerability and efficacy of the antifolate drug methotrexate-human serum albumin (MTX-HSA) were evaluated in patients with metastatic RCC who progressed after first-line immunotherapy. A total of 17 patients started treatment, and 14 (12 men, 2 women) were evaluable for response according to the phase IIa Gehan design. Patients had had prior tumor nephrectomy, were in relatively good general condition, had no impairment of renal, liver or bone marrow function, and had progressive metastatic disease after treatment with interferon-alpha (IFN-alpha) with or without cis-retinoic acid (EORTC protocols 30951 and 30947). MTX-HSA was given once a week intravenously on an outpatient basis at a dose of 50 mg/m(2). The treatment interval was prolonged in those patients who had not yet recovered from previous toxicities. Toxicity was manageable, relatively mild to moderate and reversible in most cases. Grade 2/3 mucositis (10/17) and grade 3 elevated transaminase levels (4/...Continue Reading

Citations

Mar 24, 2009·Cancer Chemotherapy and Pharmacology·Davide ColavitoAlberta Leon
Mar 26, 2005·World Journal of Urology·Gerald H Mickisch, Roland H Mattes
Oct 5, 2010·Journal of Clinical Immunology·Timothy T KuoRichard S Blumberg
Jun 17, 2011·Diabetology & Metabolic Syndrome·Eva Frei
Jan 1, 2013·Rheumatology International·Hideki MaejimaKensei Katsuoka
Oct 12, 2013·Biotechnology Advances·Shutao Guo, Leaf Huang
Jun 25, 2013·Expert Opinion on Drug Delivery·Chetan YewaleAmbikanandan Misra
Jul 1, 2010·Expert Opinion on Drug Delivery·Elena NeumannChristoph Fiehn
Jun 28, 2007·Expert Opinion on Investigational Drugs·Felix KratzAndré Warnecke
Dec 14, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Felix Kratz, Bakheet Elsadek
Jun 28, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Felix Kratz
Sep 8, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Daxing Liu, Debra T Auguste
Oct 28, 2010·Journal of Clinical Pharmacology·Reinhard DingWalter E Haefeli
Apr 1, 2003·Expert Opinion on Investigational Drugs·Mayer Fishman, Scott Antonia
Apr 30, 2015·Future Medicinal Chemistry·Angelica M MerlotDes R Richardson
Nov 26, 2013·Materials Science & Engineering. C, Materials for Biological Applications·Priyanka MurawalaB L V Prasad
Jul 17, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shunsuke KikuchiHiroyuki Nakamura
Feb 24, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lei Wang, Xiu-Li Guo
Sep 1, 2005·Organic & Biomolecular Chemistry·Wen-Hao WeiJonathan L Sessler
Dec 21, 2019·Drug Delivery·Leen Van de SandeWim Ceelen
Jul 31, 2020·Expert Opinion on Drug Metabolism & Toxicology·Diego Pilati, Kenneth A Howard
Aug 9, 2019·Cancer Chemotherapy and Pharmacology·J DelahousseA Paci
Nov 14, 2019·Biosensors·Vivian GarzónSandra Bustamante
Oct 16, 2003·Current Opinion in Urology·Edith Huland, Hans Heinzer
Sep 2, 2020·Advanced Drug Delivery Reviews·Anastasia VarankoAshutosh Chilkoti
Jul 21, 2021·International Journal of Biological Macromolecules·Hong-Yu TaoYong-Su Zhen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.